Glycogen Storage Disorders (GSD) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 64 pages | ID: GEC3B877DD9EN
VPAResearch

Abstracts

Glycogen Storage Disorders (GSD) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Glycogen Storage Disorders (GSD) disease clinical trials. The research work analyzes the ongoing Glycogen Storage Disorders (GSD) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Glycogen Storage Disorders (GSD) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Glycogen Storage Disorders (GSD) clinical trials.

Scope of the Report-

• Ongoing Glycogen Storage Disorders (GSD) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Glycogen Storage Disorders (GSD)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Glycogen Storage Disorders (GSD) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Glycogen Storage Disorders (GSD) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Glycogen Storage Disorders (GSD) Trials by Phase
3.2 Ongoing Glycogen Storage Disorders (GSD) Trials by Type
3.3 Ongoing Glycogen Storage Disorders (GSD) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Glycogen Storage Disorders (GSD) Trials
4.2 Top 10 Countries conducting Glycogen Storage Disorders (GSD) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Glycogen Storage Disorders (GSD) Trials by Sponsor Type
5.2 Glycogen Storage Disorders (GSD) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Glycogen Storage Disorders (GSD) Trials by year
6.2 Subjects Recruited for Glycogen Storage Disorders (GSD) Trials by Phase
6.3 Subjects Recruited for Glycogen Storage Disorders (GSD) Trials by Trial Type
6.4 Subjects Recruited for Glycogen Storage Disorders (GSD) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Glycogen Storage Disorders (GSD) Trials- Phase
7.2 Ongoing Glycogen Storage Disorders (GSD) Trials- Phase
7.3 Ongoing Glycogen Storage Disorders (GSD) Trials- Phase
7.4 Ongoing Glycogen Storage Disorders (GSD) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Glycogen Storage Disorders (GSD)- Clinical Trials by Country
Figure 2: Glycogen Storage Disorders (GSD)- Clinical Trials by Phase of Development, 2018
Figure 3: Glycogen Storage Disorders (GSD)- Clinical Trials by Status, 2018
Figure 4: Glycogen Storage Disorders (GSD)- Clinical Trials by Type, 2018
Figure 5: Glycogen Storage Disorders (GSD)- Clinical Trials Split by Region, 2000-2018
Figure 6: Glycogen Storage Disorders (GSD)- Clinical Trials by Type of Economy, 2018
Figure 7: Glycogen Storage Disorders (GSD)- Enrolment by Phase, 2018
Figure 8: Glycogen Storage Disorders (GSD)- Enrolment by Trial Type, 2018
Figure 9: Glycogen Storage Disorders (GSD)- Enrolment by Recruitment Status, 2018
Figure 10: Glycogen Storage Disorders (GSD)- Clinical Trials by Sponsor Type, 2018
Figure 11: Glycogen Storage Disorders (GSD)- Enrolment by Type of Sponsors
Figure 12: Glycogen Storage Disorders (GSD)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Glycogen Storage Disorders (GSD)- Clinical Trials by Sponsor Type, 2018
Table 2: Glycogen Storage Disorders (GSD)- Clinical Trials by Economy Type, 2018
Table 3: Glycogen Storage Disorders (GSD)- Clinical Trials by Region, 2018
Table 4: Glycogen Storage Disorders (GSD)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Glycogen Storage Disorders (GSD)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Glycogen Storage Disorders (GSD)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Glycogen Storage Disorders (GSD)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Glycogen Storage Disorders (GSD)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Glycogen Storage Disorders (GSD)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company